You are here :
Published on: Jan 2019 | From USD $3900 | Published By: QY RESEARCH | Number Of Pages: 91
Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer.
CtDNA and CTCs have been the most explored technologies for commercial applications up to the present time.
In 2018, the global Lung Cancer Liquid Biopsy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Lung Cancer Liquid Biopsy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lung Cancer Liquid Biopsy development in United States, Europe and China.
The key players covered in this study
Biocept
Exosome Diagnostics
F. Hoffmann-La Roche
Qiagen
Accuragen
Agena Bioscience
Bard1
Bgi
Market segment by Type, the product can be split into
CTCs
CtDNA
Exosomes And RNA
Others
Market segment by Application, split into
Clinics
Hospitals
Physicians' Office Laboratories
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Lung Cancer Liquid Biopsy status, future forecast, growth opportunity, key market and key players.
To present the Lung Cancer Liquid Biopsy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Lung Cancer Liquid Biopsy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Lung Cancer Liquid Biopsy Market Size Growth Rate by Type (2014-2025)
1.4.2 CTCs
1.4.3 CtDNA
1.4.4 Exosomes And RNA
1.4.5 Others
1.5 Market by Application
1.5.1 Global Lung Cancer Liquid Biopsy Market Share by Application (2014-2025)
1.5.2 Clinics
1.5.3 Hospitals
1.5.4 Physicians' Office Laboratories
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Lung Cancer Liquid Biopsy Market Size
2.2 Lung Cancer Liquid Biopsy Growth Trends by Regions
2.2.1 Lung Cancer Liquid Biopsy Market Size by Regions (2014-2025)
2.2.2 Lung Cancer Liquid Biopsy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Lung Cancer Liquid Biopsy Market Size by Manufacturers
3.1.1 Global Lung Cancer Liquid Biopsy Revenue by Manufacturers (2014-2018)
3.1.2 Global Lung Cancer Liquid Biopsy Revenue Market Share by Manufacturers (2014-2018)
3.1.3 Global Lung Cancer Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
3.2 Lung Cancer Liquid Biopsy Key Players Head office and Area Served
3.3 Key Players Lung Cancer Liquid Biopsy Product/Solution/Service
3.4 Date of Enter into Lung Cancer Liquid Biopsy Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Lung Cancer Liquid Biopsy Market Size by Type (2014-2019)
4.2 Global Lung Cancer Liquid Biopsy Market Size by Application (2014-2019)
5 United States
5.1 United States Lung Cancer Liquid Biopsy Market Size (2014-2019)
5.2 Lung Cancer Liquid Biopsy Key Players in United States
5.3 United States Lung Cancer Liquid Biopsy Market Size by Type
5.4 United States Lung Cancer Liquid Biopsy Market Size by Application
6 Europe
6.1 Europe Lung Cancer Liquid Biopsy Market Size (2014-2019)
6.2 Lung Cancer Liquid Biopsy Key Players in Europe
6.3 Europe Lung Cancer Liquid Biopsy Market Size by Type
6.4 Europe Lung Cancer Liquid Biopsy Market Size by Application
7 China
7.1 China Lung Cancer Liquid Biopsy Market Size (2014-2019)
7.2 Lung Cancer Liquid Biopsy Key Players in China
7.3 China Lung Cancer Liquid Biopsy Market Size by Type
7.4 China Lung Cancer Liquid Biopsy Market Size by Application
8 Japan
8.1 Japan Lung Cancer Liquid Biopsy Market Size (2014-2019)
8.2 Lung Cancer Liquid Biopsy Key Players in Japan
8.3 Japan Lung Cancer Liquid Biopsy Market Size by Type
8.4 Japan Lung Cancer Liquid Biopsy Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Lung Cancer Liquid Biopsy Market Size (2014-2019)
9.2 Lung Cancer Liquid Biopsy Key Players in Southeast Asia
9.3 Southeast Asia Lung Cancer Liquid Biopsy Market Size by Type
9.4 Southeast Asia Lung Cancer Liquid Biopsy Market Size by Application
10 India
10.1 India Lung Cancer Liquid Biopsy Market Size (2014-2019)
10.2 Lung Cancer Liquid Biopsy Key Players in India
10.3 India Lung Cancer Liquid Biopsy Market Size by Type
10.4 India Lung Cancer Liquid Biopsy Market Size by Application
11 Central & South America
11.1 Central & South America Lung Cancer Liquid Biopsy Market Size (2014-2019)
11.2 Lung Cancer Liquid Biopsy Key Players in Central & South America
11.3 Central & South America Lung Cancer Liquid Biopsy Market Size by Type
11.4 Central & South America Lung Cancer Liquid Biopsy Market Size by Application
12 International Players Profiles
12.1 Biocept
12.1.1 Biocept Company Details
12.1.2 Company Description and Business Overview
12.1.3 Lung Cancer Liquid Biopsy Introduction
12.1.4 Biocept Revenue in Lung Cancer Liquid Biopsy Business (2014-2019)
12.1.5 Biocept Recent Development
12.2 Exosome Diagnostics
12.2.1 Exosome Diagnostics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Lung Cancer Liquid Biopsy Introduction
12.2.4 Exosome Diagnostics Revenue in Lung Cancer Liquid Biopsy Business (2014-2019)
12.2.5 Exosome Diagnostics Recent Development
12.3 F. Hoffmann-La Roche
12.3.1 F. Hoffmann-La Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Lung Cancer Liquid Biopsy Introduction
12.3.4 F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biopsy Business (2014-2019)
12.3.5 F. Hoffmann-La Roche Recent Development
12.4 Qiagen
12.4.1 Qiagen Company Details
12.4.2 Company Description and Business Overview
12.4.3 Lung Cancer Liquid Biopsy Introduction
12.4.4 Qiagen Revenue in Lung Cancer Liquid Biopsy Business (2014-2019)
12.4.5 Qiagen Recent Development
12.5 Accuragen
12.5.1 Accuragen Company Details
12.5.2 Company Description and Business Overview
12.5.3 Lung Cancer Liquid Biopsy Introduction
12.5.4 Accuragen Revenue in Lung Cancer Liquid Biopsy Business (2014-2019)
12.5.5 Accuragen Recent Development
12.6 Agena Bioscience
12.6.1 Agena Bioscience Company Details
12.6.2 Company Description and Business Overview
12.6.3 Lung Cancer Liquid Biopsy Introduction
12.6.4 Agena Bioscience Revenue in Lung Cancer Liquid Biopsy Business (2014-2019)
12.6.5 Agena Bioscience Recent Development
12.7 Bard1
12.7.1 Bard1 Company Details
12.7.2 Company Description and Business Overview
12.7.3 Lung Cancer Liquid Biopsy Introduction
12.7.4 Bard1 Revenue in Lung Cancer Liquid Biopsy Business (2014-2019)
12.7.5 Bard1 Recent Development
12.8 Bgi
12.8.1 Bgi Company Details
12.8.2 Company Description and Business Overview
12.8.3 Lung Cancer Liquid Biopsy Introduction
12.8.4 Bgi Revenue in Lung Cancer Liquid Biopsy Business (2014-2019)
12.8.5 Bgi Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Lung Cancer Liquid Biopsy Key Market Segments
Table Key Players Lung Cancer Liquid Biopsy Covered
Table Global Lung Cancer Liquid Biopsy Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Lung Cancer Liquid Biopsy Market Size Market Share by Type 2014-2025
Figure CTCs Figures
Table Key Players of CTCs
Figure CtDNA Figures
Table Key Players of CtDNA
Figure Exosomes And RNA Figures
Table Key Players of Exosomes And RNA
Figure Others Figures
Table Key Players of Others
Table Global Lung Cancer Liquid Biopsy Market Size Growth by Application 2014-2025 (Million US$)
Figure Clinics Case Studies
Figure Hospitals Case Studies
Figure Physicians' Office Laboratories Case Studies
Figure Lung Cancer Liquid Biopsy Report Years Considered
Table Global Lung Cancer Liquid Biopsy Market Size 2014-2025 (Million US$)
Figure Global Lung Cancer Liquid Biopsy Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Lung Cancer Liquid Biopsy Market Size by Regions 2014-2025 (Million US$)
Table Global Lung Cancer Liquid Biopsy Market Size by Regions 2014-2019 (Million US$)
Table Global Lung Cancer Liquid Biopsy Market Share by Regions 2014-2019
Figure Global Lung Cancer Liquid Biopsy Market Share by Regions 2014-2019
Figure Global Lung Cancer Liquid Biopsy Market Share by Regions 2019
Table Market Top Trends
Table Global Lung Cancer Liquid Biopsy Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Lung Cancer Liquid Biopsy Market Share by Manufacturers (2014-2019)
Figure Global Lung Cancer Liquid Biopsy Market Share by Manufacturers in 2018
Table Global Lung Cancer Liquid Biopsy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Lung Cancer Liquid Biopsy Product/Solution/Service
Table Date of Enter into Lung Cancer Liquid Biopsy Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Lung Cancer Liquid Biopsy Market Size by Type (2014-2019) (Million US$)
Table Global Lung Cancer Liquid Biopsy Market Size Share by Type (2014-2019)
Figure Global Lung Cancer Liquid Biopsy Market Size Market Share by Type (2014-2019)
Table Global Lung Cancer Liquid Biopsy Market Size by Application (2014-2019) (Million US$)
Table Global Lung Cancer Liquid Biopsy Market Size Share by Application (2014-2019)
Figure Global Lung Cancer Liquid Biopsy Market Size Market Share by Application (2014-2019)
Figure Global Lung Cancer Liquid Biopsy Revenue Market Share by Application in 2018
Figure United States Lung Cancer Liquid Biopsy Market Size 2014-2019 (Million US$)
Table United States Key Players Lung Cancer Liquid Biopsy Revenue (2018-2019) (Million US$)
Table United States Key Players Lung Cancer Liquid Biopsy Market Share (2018-2019)
Table United States Lung Cancer Liquid Biopsy Market Size by Type (2014-2019) (Million US$)
Table United States Lung Cancer Liquid Biopsy Market Share by Type (2014-2019)
Table United States Lung Cancer Liquid Biopsy Market Size by Application (2014-2019) (Million US$)
Table United States Lung Cancer Liquid Biopsy Market Share by Application (2014-2019)
Figure Europe Lung Cancer Liquid Biopsy Market Size 2014-2019 (Million US$)
Table Europe Key Players Lung Cancer Liquid Biopsy Revenue (2018-2019) (Million US$)
Table Europe Key Players Lung Cancer Liquid Biopsy Market Share (2018-2019)
Table Europe Lung Cancer Liquid Biopsy Market Size by Type (2014-2019) (Million US$)
Table Europe Lung Cancer Liquid Biopsy Market Share by Type (2014-2019)
Table Europe Lung Cancer Liquid Biopsy Market Size by Application (2014-2019) (Million US$)
Table Europe Lung Cancer Liquid Biopsy Market Share by Application (2014-2019)
Figure China Lung Cancer Liquid Biopsy Market Size 2014-2019 (Million US$)
Table China Key Players Lung Cancer Liquid Biopsy Revenue (2018-2019) (Million US$)
Table China Key Players Lung Cancer Liquid Biopsy Market Share (2018-2019)
Table China Lung Cancer Liquid Biopsy Market Size by Type (2014-20189) (Million US$)
Table China Lung Cancer Liquid Biopsy Market Share by Type (2014-2019)
Table China Lung Cancer Liquid Biopsy Market Size by Application (2014-2019) (Million US$)
Table China Lung Cancer Liquid Biopsy Market Share by Application (2014-2019)
Figure Japan Lung Cancer Liquid Biopsy Market Size 2014-2019 (Million US$)
Table Japan Key Players Lung Cancer Liquid Biopsy Revenue (2018-2019) (Million US$)
Table Japan Key Players Lung Cancer Liquid Biopsy Market Share (2018-2019)
Table Japan Lung Cancer Liquid Biopsy Market Size by Type (2014-2019) (Million US$)
Table Japan Lung Cancer Liquid Biopsy Market Share by Type (2014-2019)
Table Japan Lung Cancer Liquid Biopsy Market Size by Application (2014-2019) (Million US$)
Table Japan Lung Cancer Liquid Biopsy Market Share by Application (2014-2019)
Figure Southeast Asia Lung Cancer Liquid Biopsy Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Lung Cancer Liquid Biopsy Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Lung Cancer Liquid Biopsy Market Share (2018-2019)
Table Southeast Asia Lung Cancer Liquid Biopsy Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Lung Cancer Liquid Biopsy Market Share by Type (2014-2019)
Table Southeast Asia Lung Cancer Liquid Biopsy Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Lung Cancer Liquid Biopsy Market Share by Application (2014-2019)
Figure India Lung Cancer Liquid Biopsy Market Size 2014-2019 (Million US$)
Table India Key Players Lung Cancer Liquid Biopsy Revenue (2018-2019) (Million US$)
Table India Key Players Lung Cancer Liquid Biopsy Market Share (2018-2019)
Table India Lung Cancer Liquid Biopsy Market Size by Type (2014-2019) (Million US$)
Table India Lung Cancer Liquid Biopsy Market Share by Type (2014-2019)
Table India Lung Cancer Liquid Biopsy Market Size by Application (2014-2019) (Million US$)
Table India Lung Cancer Liquid Biopsy Market Share by Application (2014-2019)
Figure Central & South America Lung Cancer Liquid Biopsy Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Lung Cancer Liquid Biopsy Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Lung Cancer Liquid Biopsy Market Share (2018-2019)
Table Central & South America Lung Cancer Liquid Biopsy Market Size by Type (2014-2019) (Million US$)
Table Central & South America Lung Cancer Liquid Biopsy Market Share by Type (2014-2019)
Table Central & South America Lung Cancer Liquid Biopsy Market Size by Application (2014-2019) (Million US$)
Table Central & South America Lung Cancer Liquid Biopsy Market Share by Application (2014-2019)
Table Biocept Company Details
Table Biocept Revenue in Lung Cancer Liquid Biopsy Business (2014-2019) (Million US$)
Figure Biocept Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2014-2019)
Table Biocept Recent Development
Table Exosome Diagnostics Company Details
Table Exosome Diagnostics Revenue in Lung Cancer Liquid Biopsy Business (2014-2019)(Million US$)
Figure Exosome Diagnostics Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2014-2019)
Table Exosome Diagnostics Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biopsy Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Qiagen Company Details
Table Qiagen Revenue in Lung Cancer Liquid Biopsy Business (2014-2019)(Million US$)
Figure Qiagen Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2014-2019)
Table Qiagen Recent Development
Table Accuragen Company Details
Table Accuragen Revenue in Lung Cancer Liquid Biopsy Business (2014-2019)(Million US$)
Figure Accuragen Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2014-2019)
Table Accuragen Recent Development
Table Agena Bioscience Company Details
Table Agena Bioscience Revenue in Lung Cancer Liquid Biopsy Business (2014-2019)(Million US$)
Figure Agena Bioscience Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2014-2019)
Table Agena Bioscience Recent Development
Table Bard1 Company Details
Table Bard1 Revenue in Lung Cancer Liquid Biopsy Business (2014-2019)(Million US$)
Figure Bard1 Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2014-2019)
Table Bard1 Recent Development
Table Bgi Company Details
Table Bgi Revenue in Lung Cancer Liquid Biopsy Business (2014-2019)(Million US$)
Figure Bgi Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2014-2019)
Table Bgi Recent Development
Table Global Lung Cancer Liquid Biopsy Market Size by Regions (Million US$) 2019-2025
Figure Global Lung Cancer Liquid Biopsy Market Size Share by Regions (2019-2025)
Figure Global Lung Cancer Liquid Biopsy Market Size Share by Regions in 2025
Figure United States Lung Cancer Liquid Biopsy Market Size Forecast (2019-2025)(Million USD)
Figure Europe Lung Cancer Liquid Biopsy Market Size Forecast (2019-2025)(Million USD)
Figure China Lung Cancer Liquid Biopsy Market Size Forecast (2019-2025)(Million USD)
Figure Japan Lung Cancer Liquid Biopsy Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Lung Cancer Liquid Biopsy Market Size Forecast (2019-2025)(Million USD)
Figure India Lung Cancer Liquid Biopsy Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Lung Cancer Liquid Biopsy Market Size Forecast (2019-2025)(Million USD)
Table Global Lung Cancer Liquid Biopsy Market Size by Product (2019-2025) (Million US$)
Figure Global Lung Cancer Liquid Biopsy Market Size by Product (2019-2025)
Figure Global Lung Cancer Liquid Biopsy Market Size by Product in 2025
Table Global Lung Cancer Liquid Biopsy Market Size by Application (2019-2025) (Million US$)
Figure Global Lung Cancer Liquid Biopsy Market Size by Application (2019-2025)
Figure Global Lung Cancer Liquid Biopsy Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.